Cantor Fitzgerald Analyst Recommendations & Stock Picks

Name: Community Performance Rating
Item: Cantor Fitzgerald
Rating: 2.7
Author: MarketBeat

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Cantor Fitzgerald. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Cantor Fitzgerald.

Company	Date	Action	Brokerage	Analyst	Rating	Price Target	Impact on Price
EVLV Evolv Technologies	8/11/2023	Target Raised by	Cantor Fitzgerald		Overweight -> Overweight	$7.10 -> $8.60	Low
EVLV Evolv Technologies	8/11/2023	Target Raised by	Cantor Fitzgerald		Overweight -> Overweight	$7.10 -> $8.60	Low
CPRX Catalyst Pharmaceuticals	8/11/2023	Target Raised by	Cantor Fitzgerald		Overweight -> Overweight	$25.00 -> $27.00	Low
AVTA Avantax	8/11/2023	Target Lowered by	Cantor Fitzgerald		Overweight -> Overweight	$29.00 -> $27.00	Low
ALXO ALX Oncology	8/11/2023	Target Lowered by	Cantor Fitzgerald		Overweight -> Overweight	$22.00 -> $18.00	Low
HYLN Hyliion	8/10/2023	Target Lowered by	Cantor Fitzgerald		Neutral -> Neutral	$3.00 -> $2.00	Low
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
ADMA ADMA Biologics	8/10/2023	Target Raised by	Cantor Fitzgerald		Overweight -> Overweight	$5.00 -> $6.00	Low
DNLI Denali Therapeutics	8/10/2023	Reiterated by	Cantor Fitzgerald		Overweight -> Overweight	$85.00	Low
ISPO Inspirato	8/10/2023	Target Lowered by	Cantor Fitzgerald		Overweight -> Overweight	$2.90 -> $2.40	Low
SIBN SI-BONE	8/9/2023	Reiterated by	Cantor Fitzgerald		Overweight -> Overweight	$30.00	Low
NTLA Intellia Therapeutics	8/9/2023	Reiterated by	Cantor Fitzgerald		Overweight -> Overweight	$65.00	Low
DRRX DURECT	8/10/2023	Target Lowered by	Cantor Fitzgerald		Overweight -> Overweight	$44.00 -> $41.00	N/A
AVPT AvePoint	8/10/2023	Target Raised by	Cantor Fitzgerald		Overweight -> Overweight	$8.00 -> $10.00	N/A
ETNB 89bio	8/10/2023	Target Lowered by	Cantor Fitzgerald		Overweight -> Overweight	$41.00 -> $39.00	N/A
RBT Rubicon Technologies	8/9/2023	Target Lowered by	Cantor Fitzgerald		Overweight -> Overweight	$1.90 -> $1.40	N/A
LLY Eli Lilly and Company	8/9/2023	Reiterated by	Cantor Fitzgerald		Overweight -> Overweight	$550.00	N/A
ZLAB Zai Lab	8/10/2023	Initiated by	Cantor Fitzgerald		Overweight	$70.00	Low
SOUN SoundHound AI	8/9/2023	Target Lowered by	Cantor Fitzgerald		Overweight -> Overweight	$6.20 -> $4.20	Low
PSTX Poseida Therapeutics	8/9/2023	Target Lowered by	Cantor Fitzgerald			$17.00 -> $14.00	Low
NRDY Nerdy	8/9/2023	Target Raised by	Cantor Fitzgerald		Overweight -> Overweight	$6.00 -> $8.00	Low
TWOU 2U	8/9/2023	Target Lowered by	Cantor Fitzgerald		Overweight -> Overweight	$7.40 -> $5.30	Low
MNKD MannKind	8/8/2023	Target Raised by	Cantor Fitzgerald	Analyst O. Brayer	Overweight -> Overweight	$6.50 -> $7.50	Low
ARWR Arrowhead Pharmaceuticals	8/8/2023	Reiterated by	Cantor Fitzgerald	Analyst P. Agrawal	Overweight -> Overweight	$79.00 -> $47.00	Low
LLY Eli Lilly and Company	8/8/2023	Target Raised by	Cantor Fitzgerald			$550.00 -> $630.00	Low
STOK Stoke Therapeutics	8/8/2023	Target Lowered by	Cantor Fitzgerald		Overweight -> Overweight	$18.00 -> $14.00	Low
ANNX Annexon	8/8/2023	Target Lowered by	Cantor Fitzgerald	Analyst P. Stavropoulos	Overweight -> Overweight	$18.00 -> $13.00	Low
PTCT PTC Therapeutics	8/7/2023	Reiterated by	Cantor Fitzgerald		Overweight -> Overweight	$73.00	Low
VXRT Vaxart	8/7/2023	Target Lowered by	Cantor Fitzgerald		Overweight -> Overweight	$6.00 -> $4.00	Low
UDMY Udemy	8/4/2023	Target Lowered by	Cantor Fitzgerald			$16.00 -> $15.00	Low
SPT Sprout Social	8/4/2023	Target Lowered by	Cantor Fitzgerald			$46.00 -> $44.00	Low
ITCI Intra-Cellular Therapies	8/4/2023	Target Raised by	Cantor Fitzgerald			$90.00 -> $98.00	Low
RGLD Royal Gold	8/3/2023	Upgraded by	Cantor Fitzgerald		Hold -> Buy	$145.00	Low
JOBY Joby Aviation	8/3/2023	Target Raised by	Cantor Fitzgerald			$9.00 -> $10.00	Low
FROG JFrog	8/3/2023	Target Raised by	Cantor Fitzgerald			$27.00 -> $35.00	Low
NBIX Neurocrine Biosciences	8/2/2023	Target Raised by	Cantor Fitzgerald			$127.00 -> $135.00	Low
HRMY Harmony Biosciences	8/2/2023	Target Lowered by	Cantor Fitzgerald			$75.00 -> $71.00	Low
FRSH Freshworks	8/2/2023	Target Raised by	Cantor Fitzgerald			$18.00 -> $22.00	Low
EVEX EVE	8/1/2023	Reiterated by	Cantor Fitzgerald	Analyst A. Sheppard	Neutral -> Neutral	$7.00	Low
BMRN BioMarin Pharmaceutical	8/1/2023	Reiterated by	Cantor Fitzgerald		Overweight -> Overweight	$120.00	Low
PRTG Portage Biotech	8/1/2023	Target Lowered by	Cantor Fitzgerald		Overweight -> Overweight	$16.00 -> $11.00	Low

CDTX Cidara Therapeutics	8/1/2023	Reiterated by	Cantor Fitzgerald		Overweight -> Overweight	$5.00	Low
ANNX Annexon	8/1/2023	Reiterated by	Cantor Fitzgerald	Analyst P. Stavropoulos	Overweight -> Overweight	$18.00	Low
HCAT Health Catalyst	8/1/2023	Initiated by	Cantor Fitzgerald		Overweight -> Overweight	$16.00	Low
RIVN Rivian Automotive	8/1/2023	Downgraded by	Cantor Fitzgerald		Overweight -> Neutral	$27.00 -> $29.00	Low
JNJ Johnson & Johnson	7/31/2023	Reiterated by	Cantor Fitzgerald		Overweight -> Overweight	$215.00	Low
RETA Reata Pharmaceuticals	7/28/2023	Downgraded by	Cantor Fitzgerald	Analyst C. Duncan	Overweight -> Neutral		Low
WULF TeraWulf	7/28/2023	Initiated by	Cantor Fitzgerald		Overweight	$4.00	Low
BLTE Belite Bio	7/28/2023	Initiated by	Cantor Fitzgerald	Analyst J. Kim	Overweight	$43.00	Low
COUR Coursera	7/28/2023	Upgraded by	Cantor Fitzgerald		Neutral -> Overweight	$13.00 -> $17.00	Low
GRRR Gorilla Technology Group	7/26/2023	Initiated by	Cantor Fitzgerald		Overweight	$4.80	Low
LCTX Lineage Cell Therapeutics	7/25/2023	Reiterated by	Cantor Fitzgerald		Overweight -> Overweight	$6.00	N/A
HCM HUTCHMED	7/24/2023	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight -> Overweight	$50.00	Low
LUMO Lumos Pharma	7/24/2023	Reiterated by	Cantor Fitzgerald		Overweight -> Overweight	$14.00	Low
ALXO ALX Oncology	7/24/2023	Reiterated by	Cantor Fitzgerald		Overweight -> Overweight	$22.00	Low
RETA Reata Pharmaceuticals	7/24/2023	Target Raised by	Cantor Fitzgerald		Overweight	$110.00 -> $145.00	Low
KURA Kura Oncology	7/21/2023	Reiterated by	Cantor Fitzgerald		Overweight -> Overweight	$30.00	Low
ARAV Aravive	7/21/2023	Reiterated by	Cantor Fitzgerald		Overweight -> Overweight	$18.00	Low
LFMD LifeMD	7/21/2023	Initiated by	Cantor Fitzgerald		Overweight	$7.00	Low
GDYN Grid Dynamics	7/20/2023	Target Lowered by	Cantor Fitzgerald		Overweight	$17.00 -> $14.00	Low
AGIL AgileThought	7/20/2023	Reiterated by	Cantor Fitzgerald		Neutral -> Neutral	$2.00	Low
PTCT PTC Therapeutics	7/20/2023	Reiterated by	Cantor Fitzgerald		Overweight -> Overweight	$73.00	Low
MOND Mondee	7/20/2023	Reiterated by	Cantor Fitzgerald		Overweight -> Overweight	$13.00	Low
BITF Bitfarms	7/20/2023	Reiterated by	Cantor Fitzgerald		Overweight -> Overweight	$3.00	Low
GILD Gilead Sciences	7/19/2023	Target Lowered by	Cantor Fitzgerald		Neutral -> Neutral	$85.00 -> $80.00	Low
BMY Bristol-Myers Squibb	7/19/2023	Target Lowered by	Cantor Fitzgerald	Analyst O. Brayer	Overweight	$88.00 -> $85.00	Low
BIVI BioVie	7/18/2023	Reiterated by	Cantor Fitzgerald		Overweight -> Overweight	$11.00	Low
PRTA Prothena	7/18/2023	Reiterated by	Cantor Fitzgerald		Overweight -> Overweight	$129.00	Low
CYBR CyberArk Software	7/18/2023	Reiterated by	Cantor Fitzgerald		Overweight -> Overweight	$180.00	Low
DDOG Datadog	7/18/2023	Reiterated by	Cantor Fitzgerald	Analyst J. Ruykhaver	Overweight -> Overweight	$100.00	Low
FTNT Fortinet	7/18/2023	Reiterated by	Cantor Fitzgerald		Overweight -> Overweight	$75.00	Low
ACAD ACADIA Pharmaceuticals	7/17/2023	Target Raised by	Cantor Fitzgerald			$36.00 -> $42.00	Low
ARCT Arcturus Therapeutics	7/14/2023	Reiterated by	Cantor Fitzgerald	Analyst P. Stavropoulos	Overweight -> Overweight	$54.00	Low
RIOT Riot Platforms	7/14/2023	Target Raised by	Cantor Fitzgerald		Overweight	$12.00 -> $23.00	N/A
THRX Theseus Pharmaceuticals	7/14/2023	Target Lowered by	Cantor Fitzgerald		Overweight	$23.00 -> $7.00	N/A
PTCT PTC Therapeutics	6/30/2023	Target Lowered by	Cantor Fitzgerald		Overweight	$75.00 -> $73.00	Low
MIGI Mawson Infrastructure Group	7/11/2023	Reiterated by	Cantor Fitzgerald	Analyst J. Siegler	Overweight		Low
RANI Rani Therapeutics	7/10/2023	Reiterated by	Cantor Fitzgerald	Analyst O. Brayer	Overweight		Low
OMER Omeros	7/10/2023	Reiterated by	Cantor Fitzgerald	Analyst O. Brayer	Overweight		Low
MNKD MannKind	7/10/2023	Reiterated by	Cantor Fitzgerald	Analyst O. Brayer	Overweight		Low
HRTX Heron Therapeutics	7/10/2023	Reiterated by	Cantor Fitzgerald	Analyst O. Brayer	Overweight		Low
CERS Cerus	7/10/2023	Reiterated by	Cantor Fitzgerald	Analyst R. Osborn	Overweight		Low
ALKS Alkermes	7/10/2023	Reiterated by	Cantor Fitzgerald	Analyst C. Duncan	Overweight		Low
SLNO Soleno Therapeutics	7/11/2023	Reiterated by	Cantor Fitzgerald	Analyst K. Kluska	Overweight		Low
JAZZ Jazz Pharmaceuticals	7/10/2023	Reiterated by	Cantor Fitzgerald	Analyst B. Folkes	Overweight		Low
MLTX MoonLake Immunotherapeutics	7/3/2023	Target Raised by	Cantor Fitzgerald	Analyst P. Agrawal		$29.00 -> $65.00	Low
SMRT SmartRent	6/29/2023	Target Raised by	Cantor Fitzgerald			$5.00 -> $8.00	Low
RZLT Rezolute	6/28/2023	Target Lowered by	Cantor Fitzgerald	Analyst P. Stavropoulos		$7.00 -> $5.00	Low
SSTI SoundThinking	6/28/2023	Initiated by	Cantor Fitzgerald	Analyst J. Ruykhaver	Overweight	$31.00	Low
LLY Eli Lilly and Company	6/27/2023	Target Raised by	Cantor Fitzgerald			$485.00 -> $550.00	Low
RCEL AVITA Medical	6/27/2023	Initiated by	Cantor Fitzgerald	Analyst R. Osborn	Overweight	$23.00	Low

VSTM Verastem	6/26/2023	Target Raised by	Cantor Fitzgerald	Analyst P. Stavropoulos		$3.00 -> $34.00	Low
HUMA Humacyte	6/22/2023	Initiated by	Cantor Fitzgerald		Overweight	$6.00	Low
SOUN SoundHound AI	6/21/2023	Target Raised by	Cantor Fitzgerald			$2.80 -> $6.20	Low
ROIV Roivant Sciences	6/20/2023	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight		Low
DICE DICE Therapeutics	6/20/2023	Downgraded by	Cantor Fitzgerald	Analyst P. Agrawal	Overweight -> Neutral		Low
KE Kimball Electronics	6/15/2023	Initiated by	Cantor Fitzgerald	Analyst D. Soderberg	Overweight		Low
KDNY Chinook Therapeutics	6/12/2023	Downgraded by	Cantor Fitzgerald	Analyst C. Duncan	Overweight -> Neutral		Low
APTO Aptose Biosciences	6/12/2023	Target Raised by	Cantor Fitzgerald			$6.00 -> $38.00	Low
IRON Disc Medicine Opco	6/9/2023	Target Raised by	Cantor Fitzgerald	Analyst K. Kluska		$45.00 -> $65.00	Low
AMED Amedisys	6/6/2023	Target Raised by	Cantor Fitzgerald			$91.00 -> $100.00	Low
ZS Zscaler	6/2/2023	Target Raised by	Cantor Fitzgerald			$140.00 -> $145.00	Low
CRWD CrowdStrike	6/1/2023	Target Raised by	Cantor Fitzgerald			$160.00 -> $180.00	Low
NNOX Nano-X Imaging	5/24/2023	Target Raised by	Cantor Fitzgerald			$21.00 -> $30.00	Low
STOK Stoke Therapeutics	5/23/2023	Target Raised by	Cantor Fitzgerald			$20.00 -> $25.00	Low
RBT Rubicon Technologies	5/23/2023	Target Lowered by	Cantor Fitzgerald			$2.60 -> $1.90	Low
ECX ECARX	5/22/2023	Initiated by	Cantor Fitzgerald	Analyst D. Soderberg	Overweight	$10.00	Low
LUNR Intuitive Machines	5/19/2023	Initiated by	Cantor Fitzgerald	Analyst A. Sheppard	Overweight	$11.00	Low
BITF Bitfarms	5/19/2023	Initiated by	Cantor Fitzgerald		Overweight	$2.00	Low
AMAM Ambrx Biopharma	5/19/2023	Initiated by	Cantor Fitzgerald	Analyst L. Chen	Overweight	$25.00	Low
PFE Pfizer	5/17/2023	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight		Low
MYNZ Mainz Biomed	5/18/2023	Target Lowered by	Cantor Fitzgerald			$15.00 -> $12.00	Low
ABOS Acumen Pharmaceuticals	5/18/2023	Initiated by	Cantor Fitzgerald	Analyst P. Stavropoulos	Overweight	$13.00	Low
PRQR ProQR Therapeutics	5/17/2023	Target Lowered by	Cantor Fitzgerald	Analyst J. Kim		$5.00 -> $4.50	Low
LUCD Lucid Diagnostics	5/17/2023	Target Lowered by	Cantor Fitzgerald			$4.50 -> $4.00	Low
XNCR Xencor	5/15/2023	Reiterated by	Cantor Fitzgerald	Analyst P. Stavropoulos	Overweight		Low
VSTM Verastem	5/15/2023	Reiterated by	Cantor Fitzgerald	Analyst P. Stavropoulos	Overweight		Low
RZLT Rezolute	5/15/2023	Reiterated by	Cantor Fitzgerald	Analyst P. Stavropoulos	Overweight		Low
PLRX Pliant Therapeutics	5/15/2023	Reiterated by	Cantor Fitzgerald	Analyst P. Stavropoulos	Overweight		Low
ORTX Orchard Therapeutics	5/15/2023	Reiterated by	Cantor Fitzgerald	Analyst P. Stavropoulos	Overweight		Low
JSPR Jasper Therapeutics	5/15/2023	Reiterated by	Cantor Fitzgerald	Analyst P. Stavropoulos	Overweight		Low
IMNM Immunome	5/15/2023	Reiterated by	Cantor Fitzgerald	Analyst P. Stavropoulos	Overweight		Low
ELDN Eledon Pharmaceuticals	5/15/2023	Reiterated by	Cantor Fitzgerald	Analyst P. Stavropoulos	Overweight		Low
ARCT Arcturus Therapeutics	5/15/2023	Reiterated by	Cantor Fitzgerald	Analyst P. Stavropoulos	Overweight		Low
ANNX Annexon	5/15/2023	Reiterated by	Cantor Fitzgerald	Analyst P. Stavropoulos	Overweight		Low
CLNN Clene	5/16/2023	Target Lowered by	Cantor Fitzgerald			$5.00 -> $4.00	Low
SEEL Seelos Therapeutics	5/16/2023	Target Lowered by	Cantor Fitzgerald			$3.00 -> $2.00	Low
CBAY CymaBay Therapeutics	5/16/2023	Target Raised by	Cantor Fitzgerald			$13.00 -> $15.00	Low
FBIO Fortress Biotech	5/16/2023	Target Lowered by	Cantor Fitzgerald	Analyst J. Kim		$6.00 -> $5.00	Low
CKPT Checkpoint Therapeutics	5/16/2023	Target Lowered by	Cantor Fitzgerald			$54.00 -> $19.00	Low
OUST Ouster	5/15/2023	Reiterated by	Cantor Fitzgerald	Analyst A. Sheppard	Overweight		Low
AGIL AgileThought	5/15/2023	Downgraded by	Cantor Fitzgerald		Overweight -> Neutral		Low
HL Hecla Mining	5/12/2023	Downgraded by	Cantor Fitzgerald		Buy -> Hold		Low
AZYO Aziyo Biologics	5/12/2023	Target Lowered by	Cantor Fitzgerald			$12.00 -> $10.00	Low
VYNE VYNE Therapeutics	5/12/2023	Target Raised by	Cantor Fitzgerald			$5.00 -> $9.00	Low
SOUN SoundHound AI	5/12/2023	Target Lowered by	Cantor Fitzgerald			$3.20 -> $2.80	Low
ASXC Asensus Surgical	5/12/2023	Target Lowered by	Cantor Fitzgerald			$1.50 -> $1.30	N/A
PSNY Polestar Automotive Holding UK	5/12/2023	Target Lowered by	Cantor Fitzgerald	Analyst A. Sheppard		$7.00 -> $6.00	Low
IREN Iris Energy	5/12/2023	Upgraded by	Cantor Fitzgerald		Neutral -> Overweight	$4.00 -> $7.00	Low
SMRT SmartRent	5/11/2023	Target Raised by	Cantor Fitzgerald			$4.00 -> $5.00	Low
NXT Nextracker	5/11/2023	Target Raised by	Cantor Fitzgerald	Analyst D. Soderberg		$40.00 -> $44.00	Low

MVIS MicroVision	5/11/2023	Target Lowered by	Cantor Fitzgerald			$5.00 -> $4.00	Low
LBPH Longboard Pharmaceuticals	5/11/2023	Target Raised by	Cantor Fitzgerald			$11.00 -> $16.00	Low
HYLN Hyliion	5/11/2023	Target Lowered by	Cantor Fitzgerald			$4.00 -> $3.00	Low
AVPT AvePoint	5/11/2023	Target Raised by	Cantor Fitzgerald			$7.00 -> $8.00	Low
PRCH Porch Group	5/8/2023	Reiterated by	Cantor Fitzgerald	Analyst J. Siegler	Overweight		Low
RETA Reata Pharmaceuticals	5/10/2023	Target Lowered by	Cantor Fitzgerald			$138.00 -> $110.00	Low
ML MoneyLion	5/10/2023	Target Raised by	Cantor Fitzgerald			$3.00 -> $30.00	Low
CUTR Cutera	5/10/2023	Target Lowered by	Cantor Fitzgerald			$33.00 -> $21.00	Low
ARRY Array Technologies	5/10/2023	Target Lowered by	Cantor Fitzgerald	Analyst D. Soderberg		$26.00 -> $24.00	N/A
LVOX LiveVox	5/10/2023	Target Raised by	Cantor Fitzgerald			$2.60 -> $3.00	Low
AVTA Avantax	5/9/2023	Target Lowered by	Cantor Fitzgerald			$33.00 -> $29.00	Low
CRVS Corvus Pharmaceuticals	5/9/2023	Target Raised by	Cantor Fitzgerald			$2.00 -> $4.00	Low
PGNY Progyny	5/9/2023	Target Raised by	Cantor Fitzgerald			$44.00 -> $45.00	Low
SHLS Shoals Technologies Group	5/9/2023	Target Lowered by	Cantor Fitzgerald	Analyst D. Soderberg		$30.00 -> $27.00	Low
LCID Lucid Group	5/9/2023	Target Lowered by	Cantor Fitzgerald			$13.00 -> $10.00	Low
PRTA Prothena	5/8/2023	Target Raised by	Cantor Fitzgerald			$98.00 -> $120.00	Low
ITCI Intra-Cellular Therapies	5/5/2023	Target Raised by	Cantor Fitzgerald			$87.00 -> $90.00	Low
GDYN Grid Dynamics	5/5/2023	Target Lowered by	Cantor Fitzgerald			$20.00 -> $17.00	Low
CLDX Celldex Therapeutics	5/5/2023	Target Lowered by	Cantor Fitzgerald			$55.00 -> $54.00	Low
ETNB 89bio	5/5/2023	Target Raised by	Cantor Fitzgerald	Analyst K. Kluska		$40.00 -> $41.00	Low
FTNT Fortinet	5/5/2023	Target Raised by	Cantor Fitzgerald			$70.00 -> $75.00	Low
LICY Li-Cycle	5/4/2023	Initiated by	Cantor Fitzgerald		Buy		Low
FATE Fate Therapeutics	5/4/2023	Target Lowered by	Cantor Fitzgerald	Analyst L. Watsek		$8.00 -> $5.00	Low
UDMY Udemy	5/4/2023	Target Lowered by	Cantor Fitzgerald			$18.00 -> $16.00	Low
SPT Sprout Social	5/3/2023	Target Lowered by	Cantor Fitzgerald			$52.00 -> $46.00	Low
SRPT Sarepta Therapeutics	5/3/2023	Target Lowered by	Cantor Fitzgerald			$165.00 -> $158.00	Low
PACB Pacific Biosciences of California	5/3/2023	Target Raised by	Cantor Fitzgerald	Analyst R. Osborn		$12.00 -> $13.00	Low
HRMY Harmony Biosciences	5/3/2023	Target Raised by	Cantor Fitzgerald			$71.00 -> $75.00	Low
OXBDF Oxford Biomedica	5/3/2023	Initiated by	Cantor Fitzgerald		Overweight		Low
PLRX Pliant Therapeutics	5/1/2023	Target Raised by	Cantor Fitzgerald			$52.00 -> $63.00	Low
LLY Eli Lilly and Company	4/28/2023	Target Raised by	Cantor Fitzgerald			$432.00 -> $485.00	Low
COUR Coursera	4/28/2023	Target Lowered by	Cantor Fitzgerald			$14.00 -> $13.00	Low
NET Cloudflare	4/28/2023	Target Lowered by	Cantor Fitzgerald			$65.00 -> $50.00	Low
ASND Ascendis Pharma A/S	4/28/2023	Target Raised by	Cantor Fitzgerald			$142.00 -> $152.00	Low
IRON Disc Medicine Opco	4/28/2023	Initiated by	Cantor Fitzgerald	Analyst K. Kluska	Overweight	$45.00	Low
TWOU 2U	4/27/2023	Upgraded by	Cantor Fitzgerald		Neutral -> Overweight	$7.40	Low
PSNY Polestar Automotive Holding UK	4/27/2023	Initiated by	Cantor Fitzgerald	Analyst A. Sheppard	Overweight	$7.00	Low
RARE Ultragenyx Pharmaceutical	4/26/2023	Initiated by	Cantor Fitzgerald	Analyst K. Kluska	Overweight	$114.00	Low
ZFOX ZeroFox	4/25/2023	Initiated by	Cantor Fitzgerald	Analyst J. Ruykhaver	Overweight	$3.00	Low
XENE Xenon Pharmaceuticals	4/25/2023	Initiated by	Cantor Fitzgerald	Analyst C. Duncan	Overweight	$58.00	Low
HUM Humana	4/20/2023	Initiated by	Cantor Fitzgerald	Analyst S. James	Overweight	$597.00	Low
UNH UnitedHealth Group	4/20/2023	Initiated by	Cantor Fitzgerald	Analyst S. James	Overweight	$591.00	Low
CNC Centene	4/20/2023	Initiated by	Cantor Fitzgerald	Analyst S. James	Overweight	$80.00	Low
SGRY Surgery Partners	4/20/2023	Initiated by	Cantor Fitzgerald		Overweight	$43.00	Low
THC Tenet Healthcare	4/20/2023	Initiated by	Cantor Fitzgerald		Overweight	$73.00	Low
MOH Molina Healthcare	4/20/2023	Initiated by	Cantor Fitzgerald	Analyst S. James	Overweight	$354.00	Low
HCA HCA Healthcare	4/20/2023	Initiated by	Cantor Fitzgerald		Overweight	$304.00	Low
ELV Elevance Health	4/20/2023	Initiated by	Cantor Fitzgerald	Analyst S. James	Overweight	$547.00	Low
CI The Cigna Group	4/20/2023	Initiated by	Cantor Fitzgerald	Analyst S. James	Neutral	$285.00	Low
ACHC Acadia Healthcare	4/20/2023	Initiated by	Cantor Fitzgerald		Neutral	$83.00	Low

PGNY Progyny	4/20/2023	Initiated by	Cantor Fitzgerald		Overweight	$44.00	Low
DCGO DocGo	4/20/2023	Initiated by	Cantor Fitzgerald		Overweight	$11.00	Low
AMED Amedisys	4/20/2023	Initiated by	Cantor Fitzgerald		Neutral	$87.00	Low
CVS CVS Health	4/20/2023	Initiated by	Cantor Fitzgerald	Analyst S. James	Overweight	$87.00	Low
UHS Universal Health Services	4/20/2023	Initiated by	Cantor Fitzgerald		Underweight	$143.00	Low
RGLD Royal Gold	4/20/2023	Downgraded by	Cantor Fitzgerald		Buy -> Hold		Low
SYM Symbotic	4/20/2023	Target Raised by	Cantor Fitzgerald		Overweight	$24.00 -> $35.00	Low
TGTX TG Therapeutics	4/17/2023	Reiterated by	Cantor Fitzgerald		Overweight	$24.00	N/A
CRSP CRISPR Therapeutics	4/13/2023	Initiated by	Cantor Fitzgerald	Analyst O. Brayer	Overweight	$72.00	Low
KALV KalVista Pharmaceuticals	4/11/2023	Reiterated by	Cantor Fitzgerald	Analyst C. Duncan	Overweight		Low
ONCT Oncternal Therapeutics	4/6/2023	Downgraded by	Cantor Fitzgerald	Analyst L. Watsek	Overweight -> Neutral		Low
FENC Fennec Pharmaceuticals	4/6/2023	Target Raised by	Cantor Fitzgerald	Analyst C. Duncan	Overweight	$12.00 -> $16.00	Low
ZYNE Zynerba Pharmaceuticals	3/31/2023	Reiterated by	Cantor Fitzgerald	Analyst C. Duncan	Overweight		Low
SPRO Spero Therapeutics	3/31/2023	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight		Low
FBIO Fortress Biotech	4/3/2023	Reiterated by	Cantor Fitzgerald	Analyst J. Kim	Overweight		Low
ONCT Oncternal Therapeutics	4/4/2023	Target Lowered by	Cantor Fitzgerald	Analyst L. Watsek	Overweight	$4.00 -> $1.30	Low
BHVN Biohaven	4/4/2023	Target Raised by	Cantor Fitzgerald	Analyst C. Duncan	Overweight	$27.00 -> $31.00	Low
ATNM Actinium Pharmaceuticals	4/4/2023	Target Raised by	Cantor Fitzgerald			$26.00 -> $27.00	N/A
CSGS CSG Systems International	4/4/2023	Initiated by	Cantor Fitzgerald	Analyst B. Knoblauch	Overweight		Low
CYTK Cytokinetics	4/3/2023	Target Lowered by	Cantor Fitzgerald		Overweight	$61.00 -> $59.00	Low
EVGO EVgo	3/31/2023	Reiterated by	Cantor Fitzgerald		Overweight	$10.00	Low
TSHA Taysha Gene Therapies	3/30/2023	Target Lowered by	Cantor Fitzgerald	Analyst K. Kluska	Overweight	$13.00 -> $2.00	Low
ITCI Intra-Cellular Therapies	3/29/2023	Target Raised by	Cantor Fitzgerald		Overweight	$83.00 -> $87.00	Low
ORTX Orchard Therapeutics	3/28/2023	Target Raised by	Cantor Fitzgerald	Analyst P. Stavropoulos	Overweight	$15.00	Low
RETA Reata Pharmaceuticals	3/27/2023	Target Raised by	Cantor Fitzgerald		Overweight	$121.00 -> $138.00	Low
OUST Ouster	3/24/2023	Target Lowered by	Cantor Fitzgerald			$50.00 -> $30.00	Low
ETNB 89bio	3/22/2023	Target Raised by	Cantor Fitzgerald	Analyst K. Kluska		$34.00 -> $45.00	N/A
TWOU 2U	3/22/2023	Reiterated by	Cantor Fitzgerald		Neutral	$9.50	Low
XFOR X4 Pharmaceuticals	3/22/2023	Reiterated by	Cantor Fitzgerald	Analyst K. Kluska	Overweight	$3.00	Low
SRPT Sarepta Therapeutics	3/17/2023	Target Lowered by	Cantor Fitzgerald			$178.00 -> $165.00	Low
CPRX Catalyst Pharmaceuticals	3/17/2023	Target Raised by	Cantor Fitzgerald			$22.00 -> $25.00	Low
GLTO Galecto	3/17/2023	Initiated by	Cantor Fitzgerald	Analyst K. Kluska	Overweight	$16.00	Low
REE REE Automotive	3/16/2023	Downgraded by	Cantor Fitzgerald	Analyst A. Sheppard	Overweight -> Neutral	$2.00 -> $1.00	Low
EVLO Evelo Biosciences	3/16/2023	Downgraded by	Cantor Fitzgerald	Analyst K. Kluska	Overweight -> Neutral		Low
RAPT RAPT Therapeutics	3/15/2023	Target Lowered by	Cantor Fitzgerald			$44.00 -> $40.00	Low
ANNX Annexon	3/14/2023	Target Lowered by	Cantor Fitzgerald		Overweight	$22.00 -> $18.00	Low
ACAD ACADIA Pharmaceuticals	3/14/2023	Target Raised by	Cantor Fitzgerald		Overweight	$28.00 -> $33.00	Low
CIFR Cipher Mining	3/13/2023	Initiated by	Cantor Fitzgerald		Buy	$3.00	Low
VFF Village Farms International	3/10/2023	Target Lowered by	Cantor Fitzgerald		Overweight	$7.25 -> $4.15	Low
ENVX Enovix	3/10/2023	Reiterated by	Cantor Fitzgerald	Analyst D. Soderberg	Overweight	$25.00	N/A
CLNN Clene	3/10/2023	Target Raised by	Cantor Fitzgerald		Buy	$6.00 -> $8.00	Low
BNOX Bionomics	3/10/2023	Target Lowered by	Cantor Fitzgerald			$10.00 -> $8.00	Low
SMRT SmartRent	3/9/2023	Target Lowered by	Cantor Fitzgerald		Overweight	$4.25 -> $4.00	Low
JSPR Jasper Therapeutics	3/9/2023	Reiterated by	Cantor Fitzgerald		Overweight	$6.00	Low
SOUN SoundHound AI	3/8/2023	Target Raised by	Cantor Fitzgerald			$1.60 -> $3.20	Low
DRRX DURECT	3/8/2023	Target Raised by	Cantor Fitzgerald			$37.00 -> $44.00	Low
STOK Stoke Therapeutics	3/7/2023	Reiterated by	Cantor Fitzgerald		Overweight	$20.00	N/A
CYTK Cytokinetics	3/7/2023	Reiterated by	Cantor Fitzgerald		Overweight	$61.00	N/A
ALLK Allakos	3/7/2023	Reiterated by	Cantor Fitzgerald		Overweight	$7.00	N/A
CDTX Cidara Therapeutics	3/8/2023	Reiterated by	Cantor Fitzgerald		Overweight	$5.00	Low
MRNS Marinus Pharmaceuticals	3/8/2023	Reiterated by	Cantor Fitzgerald		Overweight	$28.00	Low
KRTX Karuna Therapeutics	3/7/2023	Initiated by	Cantor Fitzgerald	Analyst C. Duncan	Neutral	$214.00	Low
ONC Oncolytics Biotech	3/6/2023	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight	C$9.00	N/A
MLTX MoonLake Immunotherapeutics	3/6/2023	Reiterated by	Cantor Fitzgerald	Analyst P. Agrawal	Overweight	$23.00	Low
ETNB 89bio	3/6/2023	Reiterated by	Cantor Fitzgerald	Analyst K. Kluska	Overweight	$34.00	Low
RIOT Riot Platforms	3/6/2023	Reiterated by	Cantor Fitzgerald		Overweight	$10.00	N/A
ONCY Oncolytics Biotech	3/6/2023	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight		Low
ZS Zscaler	3/3/2023	Target Lowered by	Cantor Fitzgerald	Analyst J. Ruykhaver		$160.00 -> $140.00	Low
NXT Nextracker	3/3/2023	Initiated by	Cantor Fitzgerald	Analyst D. Soderberg	Overweight	$40.00	Low
HCM HUTCHMED	3/1/2023	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight		Low

MarketBeat Community Rating for Cantor Fitzgerald

Community Ranking:		2.7 out of 5 ( 2.7 of 5 stars)
Outperform Votes:		20,810 (Vote Outperform)
Underperform Votes:		17,462 (Vote Underperform)
Total Votes:		38,272

MarketBeat's community ratings are surveys of what our community members think about Cantor Fitzgerald and other research firms. Vote "Outperform" if you believe Cantor Fitzgerald's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Cantor Fitzgerald's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Stock Ratings Reports and Tools

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

Ratings for Popular Stocks:

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Cantor Fitzgerald Analyst Recommendations & Stock Picks

MarketBeat Community Rating for Cantor Fitzgerald

Stock Ratings Reports and Tools

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info